Thus, COVID-19 stokes inflammasomes and [83] the relevance of NLRP3 inflammasomes as a potential therapeutic target to manage clinical manifestation of COVID-19 have been discussed [84]. The gene discussed is NLRP3; the disease is COVID-19.